<SUBMISSION>
<ACCESSION-NUMBER>0001079973-04-000006
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>2
<PERIOD>20040108
<ITEMS>5
<ITEMS>7
<FILING-DATE>20040108
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>ASPENBIO INC
<CIK>0001167419
<ASSIGNED-SIC>2835
<IRS-NUMBER>841553387
<STATE-OF-INCORPORATION>CO
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>000-50019
<FILM-NUMBER>04515454
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>1585 S. PERRY STREET
<STREET2>ASPENBIO INC.
<CITY>CASTLE ROCK
<STATE>CO
<ZIP>80104
<PHONE>(303) 794-2000
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>1585 S. PERRY STREET
<STREET2>ASPENBIO INC.
<CITY>CASTLE ROCK
<STATE>CO
<ZIP>80104
</MAIL-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>aspbio_8k1804.txt
<DESCRIPTION>CURRENT EVENT REPORT
<TEXT>
                     U.S. SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549



                                    FORM 8-K

                                 CURRENT REPORT
     PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


         Date of report (Date of earliest event reported):    January 8, 2004
                                                              ---------------

                                 ASPENBIO, INC.
               --------------------------------------------------
               (Exact Name of Registrant as Specified in Charter)


Commission file number: 0-50019
                        -------

         Colorado                                         84-1553387
----------------------------------          ------------------------------------
(State or other jurisdiction                (I.R.S. Employer Identification No.)
of incorporation or organization)


1585 S. Perry Street, Castle Rock, CO                                   80104
----------------------------------------                              ----------
(Address of principal executive offices)                              (Zip Code)


                                 (303) 794-2000
              -----------------------------------------------------
               Registrant's telephone number, including area code

<PAGE>

                                 AspenBio, Inc.

Information to be Included In the Report

Item 5.  Other Events and Regulation FD Disclosure.

     On January 7, 2004, the Company issued a news release, a copy of which is
attached hereto as Exhibit 99.1.

Item 7.  Financial Statements and Exhibits.

(c) Exhibits.

          99.1 News Release, dated January 7, 2004.



                                   SIGNATURES

In accordance with the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned, hereunto duly authorized.


                                                   AspenBio, Inc.
                                                   (Registrant)


Date: January 8, 2004                            /s/ Roger D. Hurst
      ---------------                              -------------------
                                                   Roger D. Hurst
                                                   President






<PAGE>


</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>aspbio_ex991.txt
<DESCRIPTION>PRESS RELEASE
<TEXT>



                                                                    Exhibit 99.1




For Immediate Release                   For additional information contact:
                                        J.W. Roth, AspenBio, Inc. (303) 794-2000



    AspenBio, Inc. Announces The Completion of a $1,083,750 Private Placement
    -------------------------------------------------------------------------

Castle Rock, CO, January 7, 2004/PR News - AspenBio, Inc. (OTCBB: APNB)
announced today that it has completed a Private Placement of 1,083,750 shares of
common stock at $1.00 per share. Placement Agent for the transaction was Berry
Shino Securities.

This news release includes "forward looking statements" of AspenBio, Inc.
("APNB") as defined by the Securities and Exchange Commission (the "SEC"). All
statements, other than statements of historical fact, included in the press
release that address activities, events or developments that APNB believes or
anticipates will or may occur in the future are forward-looking statements.
These statements are based on certain assumptions made based on experience,
expected future developments and other factors APNB believes are appropriate in
the circumstances. Such statements are subject to a number of assumptions, risks
and uncertainties, many of which are beyond the control of APNB. Investors are
cautioned that any such statements are not guarantees of future performance.
Actual results or developments may differ materially from those projected in the
forward-looking statements as a result of many factors, including development of
new products, obtaining additional funding, adverse changes in market
conditions, fluctuations in sales volumes, and problems in collecting
receivables. Furthermore, APNB does not intend (and is not obligated) to update
publicly any forward-looking statements. The contents of this news release
should be considered in conjunction with the warnings and cautionary statements
contained in APNB's recent filings with the SEC.



<PAGE>

</TEXT>
</DOCUMENT>
</SUBMISSION>
